Thermo Fisher CEO Casper sells $8.6m in stock, exercises options

Thermo Fisher Scientific CEO Marc N. Casper sold $8.6 million worth of company stock and exercised stock options on August 5, 2026. The transactions were part of a pre-approved trading plan from April 27, 2026. The stock price of TMO was $588.29 at the time, having increased by more than 20% over the past year. Casper disposed of 15,000 shares, with prices varying from $566.25 to $577.56.

Of these, 10,000 shares were sold directly and 5,000 shares were sold indirectly via Floral Park Associates, Inc. On the same day, Casper bought 10,000 shares by exercising options at $309.63 per share, totaling $3,096,300. The options had been vested in four equal payments between February 25, 2021, and February 25, 2024. After these transactions, Casper owns 123,925.358 shares directly and 9,608 shares indirectly through Floral Park Associates, Inc. He also holds 30,550 derivative stock options.

Recently, Thermo Fisher reported better-than-expected Q2 2026 results, with adjusted earnings of $6.03 per share and revenue of $11.99 billion, surpassing analyst estimates. The company's full-year outlook now includes a 10% revenue growth forecast and a 5% organic revenue growth rate. Improved customer activity across various sectors, including pharma, biotech, academia, and government, contributed to the revenue growth.

The company's adjusted operating margin increased to 22.8% from 21.9% the previous year, driven partly by recent acquisitions.